Sinha I - Search Results

1

Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review.

Quinn LA, Shields MD, Sinha I, Groves HE. Quinn LA, et al. Among authors: sinha i. Syst Rev. 2020 Nov 25;9(1):269. doi: 10.1186/s13643-020-01527-y. Syst Rev. 2020. PMID: 33239107 Free PMC article.

2

The ERS approach to e-cigarettes is entirely rational.

Bush A, Bhatt JM, Carroll W, Child F, Connett G, Doull I, Gilchrist F, Grigg J, Langton-Hewer S, Legg J, Lenney W, Paton J, Shields M, Sinha I. Bush A, et al. Among authors: sinha i. Eur Respir J. 2020 May 7;55(5):2000413. doi: 10.1183/13993003.00413-2020. Print 2020 May. Eur Respir J. 2020. PMID: 32381632 Free article. No abstract available.

3

Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).

Southern KW, Murphy J, Sinha IP, Nevitt SJ. Southern KW, et al. Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD010966. doi: 10.1002/14651858.CD010966.pub3. Cochrane Database Syst Rev. 2020. PMID: 33331662 Free PMC article. Updated.

4

Respiratory syncytial virus bronchiolitis in congenital diaphragmatic hernia: A systematic review of prevalence rates and palivizumab prophylaxis.

Lewis L, Sinha I, Losty PD. Lewis L, et al. Among authors: sinha i. Pediatr Pulmonol. 2022 Jan;57(1):239-244. doi: 10.1002/ppul.25717. Epub 2021 Oct 12. Pediatr Pulmonol. 2022. PMID: 34617409

5

Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?

Quinn LA, Hirani SH, Williams TC, Sinha IP. Quinn LA, et al. Breathe (Sheff). 2021 Dec;17(4):210110. doi: 10.1183/20734735.0110-2021. Breathe (Sheff). 2021. PMID: 35035568 Free PMC article.

6

A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children.

Sinha I, Jones L, Smyth RL, Williamson PR. Sinha I, et al. PLoS Med. 2008 Apr 29;5(4):e96. doi: 10.1371/journal.pmed.0050096. PLoS Med. 2008. PMID: 18447577 Free PMC article. Review.

7

Corticosteroids for treating hypotension in preterm infants.

Ibrahim H, Sinha IP, Subhedar NV. Ibrahim H, et al. Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003662. doi: 10.1002/14651858.CD003662.pub4. Cochrane Database Syst Rev. 2011. PMID: 22161379 Free PMC article. Review.

8

Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.

Patel S, Sinha IP, Dwan K, Echevarria C, Schechter M, Southern KW. Patel S, et al. Cochrane Database Syst Rev. 2015 Mar 26;(3):CD009841. doi: 10.1002/14651858.CD009841.pub2. Cochrane Database Syst Rev. 2015. PMID: 25811419 Updated. Review.

9

Aslam AA, Higgins C, Sinha IP, Southern KW. Aslam AA, et al. Cochrane Database Syst Rev. 2017 Jan 19;1(1):CD012040. doi: 10.1002/14651858.CD012040.pub2. Cochrane Database Syst Rev. 2017. PMID: 28102546 Free PMC article. Updated. Review.

10

Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.

Southern KW, Patel S, Sinha IP, Nevitt SJ. Southern KW, et al. Cochrane Database Syst Rev. 2018 Aug 2;8(8):CD010966. doi: 10.1002/14651858.CD010966.pub2. Cochrane Database Syst Rev. 2018. PMID: 30070364 Free PMC article. Updated. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

398 results

Search Page